Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 126

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 126
---
 of the Company (or its subsidiary) in
respect of any act, matter, deed or thing whatsoever made, done, committed, permitted, omitted or acquiesced in by the indemnified party
as a director, officer or employee of the Company (or its subsidiary).

Share Capitalization

Our authorized share capital structure consists of
an unlimited number of shares of the following classes (all classes are without nominal or par value): Common Shares; and first preferred
shares (the “ First Preferred Shares”) and second preferred shares (the “Second Preferred Shares”
and, together with the First Preferred Shares, the “Preferred Shares”), both issuable in series. As of April 8, 2025, we had 3,146,225 common shares issued and outstanding,
as well as, 51,527 stock options, 64,750 deferred share units and 662,534 warrants outstanding. Each stock option, deferred share unit and warrant is exercisable for one common share. No Preferred Shares have been issued
to date.

  85  

Common Shares

The holders of the Common Shares are entitled to
one vote for each Common Share held by them at all meetings of shareholders, except meetings at which only shareholders of a specified
class of shares are entitled to vote. In addition, the holders are entitled to receive dividends if, as and when declared by our Board
on the Common Shares. Finally, the holders of the Common Shares are entitled to receive our remaining property upon any liquidation,
dissolution or winding-up of our affairs, whether voluntary or involuntary. Shareholders have no liability to further capital calls as
all shares issued and outstanding are fully paid and non-assessable.

Preferred Shares

The First and Second Preferred Shares are issuable
in series with rights and privileges specific to each class. The holders of Preferred Shares are generally not entitled to receive notice
of or to attend or vote at meetings of shareholders. The holders of First Preferred Shares are entitled to preference and priority to
any participation of holders of Second Preferred Shares, Common Shares or shares of any other class of shares of our share capital ranking
junior to the First Preferred Shares with respect to dividends and, in the event of our liquidation, the distribution of our property
upon our dissolution or winding-up, or the distribution of all or part of our assets among the shareholders, to an amount equal to the
value of the consideration paid in respect of such shares outstanding, as credited to our issued and paid-up share capital, on an